RNVA — Rennova Health Balance Sheet
0.000.00%
- $0.04m
- $11.39m
- $18.69m
- 56
- 99
- 17
- 59
Annual balance sheet for Rennova Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.017 | 0.025 | 0.725 | 0.499 | 0.049 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.21 | 1.92 | 3.59 | 5.41 | 6.65 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.35 | 2.72 | 4.72 | 6.36 | 6.94 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.51 | 8.81 | 5.45 | 4.77 | 4.68 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 14.7 | 12.3 | 19.6 | 20.6 | 20.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 83.4 | 59.2 | 46.4 | 49.3 | 42.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 91.2 | 61.3 | 46.9 | 49.7 | 57.1 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -76.5 | -49 | -27.3 | -29.1 | -36.8 |
Total Liabilities & Shareholders' Equity | 14.7 | 12.3 | 19.6 | 20.6 | 20.3 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |